IRIS
PALOMBA, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.750
EU - Europa 1.651
AS - Asia 1.214
SA - Sud America 176
AF - Africa 45
OC - Oceania 1
Totale 4.837
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.717
RU - Federazione Russa 963
SG - Singapore 579
CN - Cina 341
HK - Hong Kong 243
IT - Italia 170
BR - Brasile 162
DE - Germania 108
NL - Olanda 107
FI - Finlandia 88
SE - Svezia 69
IE - Irlanda 61
UA - Ucraina 34
CA - Canada 30
GB - Regno Unito 26
CI - Costa d'Avorio 24
IN - India 16
VN - Vietnam 8
ZA - Sudafrica 8
AR - Argentina 7
TR - Turchia 7
DZ - Algeria 6
FR - Francia 6
BD - Bangladesh 5
BE - Belgio 5
LT - Lituania 4
CO - Colombia 3
CZ - Repubblica Ceca 3
MA - Marocco 3
PH - Filippine 3
BG - Bulgaria 2
EC - Ecuador 2
ES - Italia 2
ID - Indonesia 2
IQ - Iraq 2
NG - Nigeria 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BH - Bahrain 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.837
Salva come PNG Salva come JPEG
Città #
Singapore 336
Chandler 308
Moscow 247
Hong Kong 243
Millbury 168
Santa Clara 118
Princeton 114
Nanjing 105
Amsterdam 101
Naples 82
Jacksonville 68
Beijing 63
Wilmington 55
Des Moines 45
Ashburn 44
Nanchang 30
Seattle 30
Helsinki 26
Jiaxing 21
Shenyang 21
Boston 18
Hebei 18
Ottawa 17
São Paulo 15
Changsha 14
Dublin 14
Falkenstein 14
Tianjin 14
Munich 13
Napoli 12
Turku 11
Woodbridge 10
Dong Ket 8
Norwalk 8
Toronto 8
Rio de Janeiro 7
Rome 7
Brasília 6
Hefei 6
Washington 6
Boardman 5
Brooklyn 5
Frankfurt am Main 5
Kronberg 5
New York 5
Yellow Springs 5
Casandrino 4
Kunming 4
Lanzhou 4
Redwood City 4
Shanghai 4
The Dalles 4
Annaba 3
Brussels 3
Curitiba 3
Dallas 3
Falls Church 3
Fortaleza 3
Guaratuba 3
London 3
Los Angeles 3
Marrakesh 3
Phoenix 3
Pune 3
San Francisco 3
Ahmedabad 2
Ankara 2
Bagheria 2
Bragança Paulista 2
Chennai 2
Courcelles 2
Enterprise 2
Guangzhou 2
Indiana 2
Istanbul 2
Jandira 2
Johannesburg 2
João Pessoa 2
Long Beach 2
Medellín 2
Milwaukee 2
Mogi Guaçu 2
Porto Alegre 2
Recife 2
Redmond 2
Saint-Fons 2
Springfield 2
São Gonçalo 2
São José do Rio Preto 2
Tappahannock 2
Uberlândia 2
Abu Dhabi 1
Alto do Rodrigues 1
Angra dos Reis 1
Ann Arbor 1
Araquari 1
Araras 1
Araxá 1
Araçatuba 1
Asunción 1
Totale 2.605
Salva come PNG Salva come JPEG
Nome #
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 99
Cardiopulmonary impairment in young women with polycystic ovary syndrome 86
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 81
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome 77
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 75
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. 74
Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: Relationship with Bsml vitamin D receptor genotypes 72
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 72
EFFECTS OF PHYSICAL EXERCISE ON THE FEMALE REPRODUCTIVE SYSTEM. 70
Metabolic and cardiovascular consequences of polycystic ovary syndrome 67
Lifestyle changes in the management of adulthood and childhood obesity. 67
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 66
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 65
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 65
Effects of neridronate treatment in elderly women with osteoporosis 64
Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. 64
Evidence for altered adipocyte function in polycystic ovary syndrome 64
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. 63
Cardiovascular complications of obesity in adolescents 63
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 62
Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. 61
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in young women with polycystic ovary syndrome. 60
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 60
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 60
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial 59
A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: A focus on the quality of life 58
Circulating ghrelin concentrations in the polycystic ovary syndrome 57
Adiponectin levels in women with polycystic ovary syndrome 57
Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: A prospective, randomized, controlled study 57
Endothelial dysfunction in PCOS: role of obesity and adipose hormones 56
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome 55
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 55
Cardiovascular risk in women with polycystic ovary sydrome 55
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters 54
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome 54
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome 54
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study 53
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 51
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 51
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 49
Effect of different doses of progestin on uterine leiomyomas in postmenopausal women 48
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy 47
A randomized controlled trial comparing three single-incision minislings for stress urinary incontinence 47
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 47
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 46
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 46
Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy 46
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 44
Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome 44
A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes 44
Single-incision Mini-slings Versus Retropubic Tension-free Vaginal Tapes: A Multicenter Clinical Trial 43
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome 42
Polycystic ovary syndrome and obesity: non pharmacological approaches 42
Short-term administration of tibolone plus GnRH analog before laparoscopic myomectomy 42
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis 41
Bupivacaine plus epinephrine for laparoscopic myomectomy: A randomized placebo-controlled trial 41
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 40
Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women 40
Presurgical assessment of intraabdominal visceral fat in obese patients with early-stage endometrial cancer treated with laparoscopic approach: Relationships with early laparotomic conversions 40
A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes 40
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination 40
Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy 39
Laparoscopic colposuspension using sutures or prolene meshes: A 3-year follow-up 39
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 38
Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas 38
Laparoscopic burch colposuspension: A randomized controlled trial comparing two transperitoneal surgical techniques 38
Laparoscopic uterine nerve ablation versus vaginal uterosacral ligament resection in postmenopausal women with intractable midline chronic pelvic pain: A randomized study 37
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 37
Effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis who were treated with laparoscopic conservative surgery: A 1-year prospective randomized double-blind controlled trial 37
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome 36
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome 36
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 35
Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial 35
Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women 34
Does raloxifene inhibit the growth of uterine fibroids? [10] (multiple letters) 34
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 34
GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome 33
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism 33
Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone 33
Long-term Effectiveness of Presacral Neurectomy for the Treatment of Severe Dysmenorrhea Due to Endometriosis 33
Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study 32
Lack of an association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 32
Updating of a recent meta-analysis of randomized controlled trials to assess the safety and the efficacy of the laparoscopic surgery for treating early stage endometrial cancer 32
Visceral fat amount as predictive factor for early laparotomic conversion in obese patients with endometrial cancer 31
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene 30
Randomized Controlled Study Comparing the Gynecare Morcellex and Rotocut G1 Tissue Morcellators 30
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome 30
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial 30
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study 29
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 29
Raloxifene administration in premenopausal women with uterine leiomyomas: A pilot study 29
Two techniques of laparoscopic retropubic urethropexy 28
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: A comprehensive review 28
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 27
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study 27
Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome? (multiple letters) [3] 27
Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance 27
What is the best first-step therapeutic approach in treating anovulatory infertility in patients with polycystic ovary syndrome? Questions that are still unanswered 27
Lipid profile in nonobese pregnant women with polycystic ovary syndrome: A prospective controlled clinical study 26
Laparoscopic treatment for endometrial cancer: A meta-analysis of randomized controlled trials (RCTs) 25
Totale 4.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202048 0 0 0 0 0 0 0 0 0 0 0 48
2020/2021112 2 6 14 11 6 34 10 1 9 2 8 9
2021/2022600 5 0 0 4 9 54 2 25 53 57 109 282
2022/2023753 123 57 22 64 88 72 11 57 110 91 48 10
2023/2024449 21 84 110 26 18 26 0 42 4 2 67 49
2024/20252.425 132 114 21 23 43 211 259 177 195 261 907 82
Totale 4.978